Background To compare drug regimens across clinical trials in Parkinson's disease (PD)
conversion formulae between antiparkinsonian drugs have been developed. These are …

… Dafsari et al. also provide significant evidence of subjective sleep improvement after DBS.
The long-term benefit of sleep after DBS is supported by an early study by Lyons and Pahwa …

Subcutaneous apomorphine infusion (Apo) and intrajejunal levodopa infusion (IJLI) are two
treatment options for patients with advanced Parkinson's disease (PD) and refractory motor …

Objective The objective of this study was to investigate whether directional deep brain
stimulation (DBS) of the subthalamic nucleus in Parkinson's disease (PD) offers increased …

Objective To investigate whether functional sweet spots of deep brain stimulation (DBS) in
the subthalamic nucleus (STN) can predict motor improvement in Parkinson disease (PD) …

Objective Real‐life observational report of clinical efficacy of bilateral subthalamic stimulation
(STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on quality of life, …

Objective To evaluate deep brain stimulation (DBS) of the posterior subthalamic area (PSA)
in essential tremor (ET) and compare it to the ventral intermediate nucleus of the thalamus (…

Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for
patients with advanced Parkinson’s disease improving quality of life, motor symptoms and …

Background STN-DBS is well established to improve motor symptoms and quality of life in
patients with PD. While non-motor symptoms are crucial for quality of life in these patients, …

Objective Subthalamic nucleus deep brain stimulation (STN‐DBS) in Parkinson's disease (PD)
not only stimulates focal target structures but also affects distributed brain networks. The …